nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—Upset stomach—Disulfiram—alcohol dependence	0.0253	0.0269	CcSEcCtD
Salicylate-sodium—Tingling sensation—Disulfiram—alcohol dependence	0.0206	0.022	CcSEcCtD
Salicylate-sodium—Tenderness—Disulfiram—alcohol dependence	0.019	0.0202	CcSEcCtD
Salicylate-sodium—Acute bronchitis—Citalopram—alcohol dependence	0.0187	0.02	CcSEcCtD
Salicylate-sodium—Duodenal ulcer—Acamprosate—alcohol dependence	0.0169	0.018	CcSEcCtD
Salicylate-sodium—Tracheobronchitis—Citalopram—alcohol dependence	0.0162	0.0173	CcSEcCtD
Salicylate-sodium—Tetany—Citalopram—alcohol dependence	0.015	0.016	CcSEcCtD
Salicylate-sodium—Skin papilloma—Citalopram—alcohol dependence	0.015	0.016	CcSEcCtD
Salicylate-sodium—Gastric ulcer—Acamprosate—alcohol dependence	0.014	0.015	CcSEcCtD
Salicylate-sodium—Upset stomach—Naltrexone—alcohol dependence	0.0118	0.0126	CcSEcCtD
Salicylate-sodium—Abscess—Acamprosate—alcohol dependence	0.0103	0.011	CcSEcCtD
Salicylate-sodium—Abdominal bloating—Citalopram—alcohol dependence	0.0103	0.011	CcSEcCtD
Salicylate-sodium—Duodenal ulcer—Citalopram—alcohol dependence	0.0101	0.0108	CcSEcCtD
Salicylate-sodium—Throat tightness—Citalopram—alcohol dependence	0.00996	0.0106	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Disulfiram—alcohol dependence	0.00995	0.0106	CcSEcCtD
Salicylate-sodium—Epigastric discomfort—Citalopram—alcohol dependence	0.00929	0.00992	CcSEcCtD
Salicylate-sodium—Drowsiness—Disulfiram—alcohol dependence	0.00926	0.00988	CcSEcCtD
Salicylate-sodium—Creatinine increased—Acamprosate—alcohol dependence	0.00856	0.00914	CcSEcCtD
Salicylate-sodium—Cellulitis—Naltrexone—alcohol dependence	0.00848	0.00905	CcSEcCtD
Salicylate-sodium—Gastric ulcer—Citalopram—alcohol dependence	0.00841	0.00897	CcSEcCtD
Salicylate-sodium—Hepatitis—Disulfiram—alcohol dependence	0.00831	0.00887	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Disulfiram—alcohol dependence	0.00827	0.00882	CcSEcCtD
Salicylate-sodium—Ulcer—Naltrexone—alcohol dependence	0.00815	0.0087	CcSEcCtD
Salicylate-sodium—Upset stomach—Citalopram—alcohol dependence	0.00746	0.00796	CcSEcCtD
Salicylate-sodium—Oesophagitis—Acamprosate—alcohol dependence	0.00745	0.00795	CcSEcCtD
Salicylate-sodium—Ecchymosis—Acamprosate—alcohol dependence	0.00737	0.00786	CcSEcCtD
Salicylate-sodium—Heartburn—Citalopram—alcohol dependence	0.0071	0.00758	CcSEcCtD
Salicylate-sodium—Burning sensation—Citalopram—alcohol dependence	0.00703	0.0075	CcSEcCtD
Salicylate-sodium—Cyanosis—Citalopram—alcohol dependence	0.0069	0.00737	CcSEcCtD
Salicylate-sodium—Phlebitis—Acamprosate—alcohol dependence	0.00687	0.00733	CcSEcCtD
Salicylate-sodium—Deafness—Acamprosate—alcohol dependence	0.00661	0.00706	CcSEcCtD
Salicylate-sodium—Phlebitis—Naltrexone—alcohol dependence	0.0065	0.00693	CcSEcCtD
Salicylate-sodium—Renal failure acute—Acamprosate—alcohol dependence	0.00641	0.00684	CcSEcCtD
Salicylate-sodium—Swelling—Naltrexone—alcohol dependence	0.00635	0.00677	CcSEcCtD
Salicylate-sodium—Coagulopathy—Citalopram—alcohol dependence	0.00628	0.0067	CcSEcCtD
Salicylate-sodium—Disorientation—Naltrexone—alcohol dependence	0.00626	0.00668	CcSEcCtD
Salicylate-sodium—Feeling hot—Citalopram—alcohol dependence	0.00623	0.00664	CcSEcCtD
Salicylate-sodium—Abscess—Citalopram—alcohol dependence	0.00618	0.00659	CcSEcCtD
Salicylate-sodium—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00617	0.00659	CcSEcCtD
Salicylate-sodium—Lethargy—Naltrexone—alcohol dependence	0.00571	0.0061	CcSEcCtD
Salicylate-sodium—PTGS1—Eicosanoid Synthesis—GGT2—alcohol dependence	0.00571	0.091	CbGpPWpGaD
Salicylate-sodium—Blood creatinine increased—Acamprosate—alcohol dependence	0.00554	0.00591	CcSEcCtD
Salicylate-sodium—Cellulitis—Citalopram—alcohol dependence	0.00537	0.00573	CcSEcCtD
Salicylate-sodium—Irritability—Naltrexone—alcohol dependence	0.00534	0.0057	CcSEcCtD
Salicylate-sodium—Hypocalcaemia—Citalopram—alcohol dependence	0.00534	0.0057	CcSEcCtD
Salicylate-sodium—Oliguria—Citalopram—alcohol dependence	0.0053	0.00566	CcSEcCtD
Salicylate-sodium—Paraesthesia—Disulfiram—alcohol dependence	0.0053	0.00566	CcSEcCtD
Salicylate-sodium—Somnolence—Disulfiram—alcohol dependence	0.00525	0.0056	CcSEcCtD
Salicylate-sodium—Dehydration—Naltrexone—alcohol dependence	0.00521	0.00556	CcSEcCtD
Salicylate-sodium—Abdominal distension—Acamprosate—alcohol dependence	0.00515	0.00549	CcSEcCtD
Salicylate-sodium—Asthma—Acamprosate—alcohol dependence	0.00511	0.00546	CcSEcCtD
Salicylate-sodium—Dysphagia—Acamprosate—alcohol dependence	0.00511	0.00546	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Naltrexone—alcohol dependence	0.00511	0.00546	CcSEcCtD
Salicylate-sodium—Fatigue—Disulfiram—alcohol dependence	0.00509	0.00543	CcSEcCtD
Salicylate-sodium—Pain—Disulfiram—alcohol dependence	0.00505	0.00539	CcSEcCtD
Salicylate-sodium—Bronchitis—Acamprosate—alcohol dependence	0.00492	0.00525	CcSEcCtD
Salicylate-sodium—Sweating increased—Naltrexone—alcohol dependence	0.00471	0.00503	CcSEcCtD
Salicylate-sodium—Weight increased—Acamprosate—alcohol dependence	0.00465	0.00497	CcSEcCtD
Salicylate-sodium—Bronchitis—Naltrexone—alcohol dependence	0.00465	0.00497	CcSEcCtD
Salicylate-sodium—Fluid retention—Citalopram—alcohol dependence	0.00464	0.00495	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Naltrexone—alcohol dependence	0.00464	0.00495	CcSEcCtD
Salicylate-sodium—PTGS2—Eicosanoid Synthesis—GGT2—alcohol dependence	0.00453	0.0723	CbGpPWpGaD
Salicylate-sodium—Acute coronary syndrome—Acamprosate—alcohol dependence	0.0045	0.0048	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Acamprosate—alcohol dependence	0.00447	0.00477	CcSEcCtD
Salicylate-sodium—Oesophagitis—Citalopram—alcohol dependence	0.00447	0.00476	CcSEcCtD
Salicylate-sodium—Ecchymosis—Citalopram—alcohol dependence	0.00442	0.00471	CcSEcCtD
Salicylate-sodium—Weight increased—Naltrexone—alcohol dependence	0.0044	0.0047	CcSEcCtD
Salicylate-sodium—Lightheadedness—Citalopram—alcohol dependence	0.00437	0.00466	CcSEcCtD
Salicylate-sodium—Epistaxis—Acamprosate—alcohol dependence	0.0043	0.00459	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00425	0.00454	CcSEcCtD
Salicylate-sodium—Sepsis—Citalopram—alcohol dependence	0.00424	0.00452	CcSEcCtD
Salicylate-sodium—Asthenia—Disulfiram—alcohol dependence	0.00424	0.00452	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Naltrexone—alcohol dependence	0.00423	0.00451	CcSEcCtD
Salicylate-sodium—Phlebitis—Citalopram—alcohol dependence	0.00412	0.00439	CcSEcCtD
Salicylate-sodium—Hepatitis—Acamprosate—alcohol dependence	0.00409	0.00437	CcSEcCtD
Salicylate-sodium—Hallucination—Acamprosate—alcohol dependence	0.00407	0.00435	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Acamprosate—alcohol dependence	0.00407	0.00435	CcSEcCtD
Salicylate-sodium—Epistaxis—Naltrexone—alcohol dependence	0.00407	0.00434	CcSEcCtD
Salicylate-sodium—Deafness—Citalopram—alcohol dependence	0.00397	0.00423	CcSEcCtD
Salicylate-sodium—Disorientation—Citalopram—alcohol dependence	0.00397	0.00423	CcSEcCtD
Salicylate-sodium—Dizziness—Disulfiram—alcohol dependence	0.0039	0.00417	CcSEcCtD
Salicylate-sodium—Hepatitis—Naltrexone—alcohol dependence	0.00387	0.00413	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00387	0.0617	CbGpPWpGaD
Salicylate-sodium—Hallucination—Naltrexone—alcohol dependence	0.00385	0.00411	CcSEcCtD
Salicylate-sodium—Renal failure acute—Citalopram—alcohol dependence	0.00384	0.0041	CcSEcCtD
Salicylate-sodium—Tinnitus—Acamprosate—alcohol dependence	0.00382	0.00407	CcSEcCtD
Salicylate-sodium—Rash—Disulfiram—alcohol dependence	0.00372	0.00397	CcSEcCtD
Salicylate-sodium—Headache—Disulfiram—alcohol dependence	0.0037	0.00395	CcSEcCtD
Salicylate-sodium—Cerebrovascular accident—Citalopram—alcohol dependence	0.00362	0.00386	CcSEcCtD
Salicylate-sodium—Lethargy—Citalopram—alcohol dependence	0.00362	0.00386	CcSEcCtD
Salicylate-sodium—Tinnitus—Naltrexone—alcohol dependence	0.00361	0.00385	CcSEcCtD
Salicylate-sodium—Flatulence—Acamprosate—alcohol dependence	0.00351	0.00375	CcSEcCtD
Salicylate-sodium—Dysgeusia—Acamprosate—alcohol dependence	0.00349	0.00372	CcSEcCtD
Salicylate-sodium—Irritability—Citalopram—alcohol dependence	0.00339	0.00361	CcSEcCtD
Salicylate-sodium—Flatulence—Naltrexone—alcohol dependence	0.00332	0.00354	CcSEcCtD
Salicylate-sodium—Dysgeusia—Naltrexone—alcohol dependence	0.0033	0.00352	CcSEcCtD
Salicylate-sodium—Dehydration—Citalopram—alcohol dependence	0.0033	0.00352	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Citalopram—alcohol dependence	0.00324	0.00346	CcSEcCtD
Salicylate-sodium—Hypokalaemia—Citalopram—alcohol dependence	0.00323	0.00344	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00321	0.0512	CbGpPWpGaD
Salicylate-sodium—Syncope—Acamprosate—alcohol dependence	0.0032	0.00341	CcSEcCtD
Salicylate-sodium—Vision blurred—Naltrexone—alcohol dependence	0.00318	0.00339	CcSEcCtD
Salicylate-sodium—Palpitations—Acamprosate—alcohol dependence	0.00315	0.00336	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Acamprosate—alcohol dependence	0.00313	0.00334	CcSEcCtD
Salicylate-sodium—Convulsion—Acamprosate—alcohol dependence	0.00309	0.00329	CcSEcCtD
Salicylate-sodium—Abdominal distension—Citalopram—alcohol dependence	0.00309	0.00329	CcSEcCtD
Salicylate-sodium—Dysphagia—Citalopram—alcohol dependence	0.00307	0.00327	CcSEcCtD
Salicylate-sodium—Asthma—Citalopram—alcohol dependence	0.00307	0.00327	CcSEcCtD
Salicylate-sodium—Chest pain—Acamprosate—alcohol dependence	0.00303	0.00324	CcSEcCtD
Salicylate-sodium—Syncope—Naltrexone—alcohol dependence	0.00302	0.00323	CcSEcCtD
Salicylate-sodium—Anxiety—Acamprosate—alcohol dependence	0.00302	0.00323	CcSEcCtD
Salicylate-sodium—Bronchospasm—Citalopram—alcohol dependence	0.00302	0.00322	CcSEcCtD
Salicylate-sodium—Sweating increased—Citalopram—alcohol dependence	0.00299	0.00319	CcSEcCtD
Salicylate-sodium—Palpitations—Naltrexone—alcohol dependence	0.00298	0.00318	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Naltrexone—alcohol dependence	0.00296	0.00316	CcSEcCtD
Salicylate-sodium—Bronchitis—Citalopram—alcohol dependence	0.00295	0.00315	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Citalopram—alcohol dependence	0.00294	0.00314	CcSEcCtD
Salicylate-sodium—Confusional state—Acamprosate—alcohol dependence	0.00293	0.00313	CcSEcCtD
Salicylate-sodium—Convulsion—Naltrexone—alcohol dependence	0.00292	0.00312	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Acamprosate—alcohol dependence	0.00291	0.0031	CcSEcCtD
Salicylate-sodium—Infection—Acamprosate—alcohol dependence	0.00289	0.00308	CcSEcCtD
Salicylate-sodium—Chest pain—Naltrexone—alcohol dependence	0.00287	0.00306	CcSEcCtD
Salicylate-sodium—Shock—Acamprosate—alcohol dependence	0.00286	0.00305	CcSEcCtD
Salicylate-sodium—Anxiety—Naltrexone—alcohol dependence	0.00286	0.00305	CcSEcCtD
Salicylate-sodium—Tachycardia—Acamprosate—alcohol dependence	0.00284	0.00303	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Acamprosate—alcohol dependence	0.00281	0.003	CcSEcCtD
Salicylate-sodium—Weight increased—Citalopram—alcohol dependence	0.00279	0.00298	CcSEcCtD
Salicylate-sodium—Confusional state—Naltrexone—alcohol dependence	0.00277	0.00296	CcSEcCtD
Salicylate-sodium—Anorexia—Acamprosate—alcohol dependence	0.00277	0.00296	CcSEcCtD
Salicylate-sodium—Oedema—Naltrexone—alcohol dependence	0.00275	0.00294	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Naltrexone—alcohol dependence	0.00275	0.00294	CcSEcCtD
Salicylate-sodium—Infection—Naltrexone—alcohol dependence	0.00273	0.00292	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00273	0.0435	CbGpPWpGaD
Salicylate-sodium—Hypotension—Acamprosate—alcohol dependence	0.00272	0.0029	CcSEcCtD
Salicylate-sodium—Shock—Naltrexone—alcohol dependence	0.00271	0.00289	CcSEcCtD
Salicylate-sodium—PTGS1—Eicosanoid Synthesis—GGT1—alcohol dependence	0.0027	0.0431	CbGpPWpGaD
Salicylate-sodium—Acute coronary syndrome—Citalopram—alcohol dependence	0.00269	0.00288	CcSEcCtD
Salicylate-sodium—Tachycardia—Naltrexone—alcohol dependence	0.00269	0.00287	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Citalopram—alcohol dependence	0.00268	0.00286	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Naltrexone—alcohol dependence	0.00266	0.00284	CcSEcCtD
Salicylate-sodium—Anorexia—Naltrexone—alcohol dependence	0.00262	0.0028	CcSEcCtD
Salicylate-sodium—Paraesthesia—Acamprosate—alcohol dependence	0.00261	0.00279	CcSEcCtD
Salicylate-sodium—Dyspnoea—Acamprosate—alcohol dependence	0.00259	0.00277	CcSEcCtD
Salicylate-sodium—Somnolence—Acamprosate—alcohol dependence	0.00259	0.00276	CcSEcCtD
Salicylate-sodium—Epistaxis—Citalopram—alcohol dependence	0.00258	0.00275	CcSEcCtD
Salicylate-sodium—Dyspepsia—Acamprosate—alcohol dependence	0.00256	0.00273	CcSEcCtD
Salicylate-sodium—Decreased appetite—Acamprosate—alcohol dependence	0.00253	0.0027	CcSEcCtD
Salicylate-sodium—Constipation—Acamprosate—alcohol dependence	0.00249	0.00265	CcSEcCtD
Salicylate-sodium—Pain—Acamprosate—alcohol dependence	0.00249	0.00265	CcSEcCtD
Salicylate-sodium—Paraesthesia—Naltrexone—alcohol dependence	0.00247	0.00264	CcSEcCtD
Salicylate-sodium—Hepatitis—Citalopram—alcohol dependence	0.00245	0.00262	CcSEcCtD
Salicylate-sodium—Dyspnoea—Naltrexone—alcohol dependence	0.00245	0.00262	CcSEcCtD
Salicylate-sodium—Somnolence—Naltrexone—alcohol dependence	0.00245	0.00261	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Citalopram—alcohol dependence	0.00244	0.00261	CcSEcCtD
Salicylate-sodium—Hallucination—Citalopram—alcohol dependence	0.00244	0.00261	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Acamprosate—alcohol dependence	0.0024	0.00256	CcSEcCtD
Salicylate-sodium—Decreased appetite—Naltrexone—alcohol dependence	0.00239	0.00255	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00238	0.00254	CcSEcCtD
Salicylate-sodium—Fatigue—Naltrexone—alcohol dependence	0.00237	0.00253	CcSEcCtD
Salicylate-sodium—Pain—Naltrexone—alcohol dependence	0.00235	0.00251	CcSEcCtD
Salicylate-sodium—Constipation—Naltrexone—alcohol dependence	0.00235	0.00251	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Citalopram—alcohol dependence	0.00232	0.00248	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00232	0.037	CbGpPWpGaD
Salicylate-sodium—Urticaria—Acamprosate—alcohol dependence	0.00231	0.00247	CcSEcCtD
Salicylate-sodium—Abdominal pain—Acamprosate—alcohol dependence	0.0023	0.00245	CcSEcCtD
Salicylate-sodium—Body temperature increased—Acamprosate—alcohol dependence	0.0023	0.00245	CcSEcCtD
Salicylate-sodium—Tinnitus—Citalopram—alcohol dependence	0.00229	0.00244	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Naltrexone—alcohol dependence	0.00227	0.00242	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00225	0.0024	CcSEcCtD
Salicylate-sodium—Arrhythmia—Citalopram—alcohol dependence	0.00219	0.00234	CcSEcCtD
Salicylate-sodium—Urticaria—Naltrexone—alcohol dependence	0.00219	0.00233	CcSEcCtD
Salicylate-sodium—Abdominal pain—Naltrexone—alcohol dependence	0.00218	0.00232	CcSEcCtD
Salicylate-sodium—Body temperature increased—Naltrexone—alcohol dependence	0.00218	0.00232	CcSEcCtD
Salicylate-sodium—PTGS2—Eicosanoid Synthesis—GGT1—alcohol dependence	0.00214	0.0342	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Acamprosate—alcohol dependence	0.00214	0.00229	CcSEcCtD
Salicylate-sodium—Erythema—Citalopram—alcohol dependence	0.00214	0.00228	CcSEcCtD
Salicylate-sodium—Flatulence—Citalopram—alcohol dependence	0.00211	0.00225	CcSEcCtD
Salicylate-sodium—Dysgeusia—Citalopram—alcohol dependence	0.00209	0.00223	CcSEcCtD
Salicylate-sodium—Asthenia—Acamprosate—alcohol dependence	0.00209	0.00223	CcSEcCtD
Salicylate-sodium—Pruritus—Acamprosate—alcohol dependence	0.00206	0.0022	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—ADH6—alcohol dependence	0.00206	0.0328	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00203	0.0324	CbGpPWpGaD
Salicylate-sodium—Hypersensitivity—Naltrexone—alcohol dependence	0.00203	0.00216	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00202	0.0322	CbGpPWpGaD
Salicylate-sodium—Vision blurred—Citalopram—alcohol dependence	0.00201	0.00215	CcSEcCtD
Salicylate-sodium—Diarrhoea—Acamprosate—alcohol dependence	0.00199	0.00212	CcSEcCtD
Salicylate-sodium—Asthenia—Naltrexone—alcohol dependence	0.00197	0.00211	CcSEcCtD
Salicylate-sodium—Pruritus—Naltrexone—alcohol dependence	0.00195	0.00208	CcSEcCtD
Salicylate-sodium—Dizziness—Acamprosate—alcohol dependence	0.00192	0.00205	CcSEcCtD
Salicylate-sodium—Syncope—Citalopram—alcohol dependence	0.00192	0.00204	CcSEcCtD
Salicylate-sodium—Palpitations—Citalopram—alcohol dependence	0.00189	0.00201	CcSEcCtD
Salicylate-sodium—Diarrhoea—Naltrexone—alcohol dependence	0.00188	0.00201	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Citalopram—alcohol dependence	0.00188	0.002	CcSEcCtD
Salicylate-sodium—Convulsion—Citalopram—alcohol dependence	0.00185	0.00197	CcSEcCtD
Salicylate-sodium—Vomiting—Acamprosate—alcohol dependence	0.00185	0.00197	CcSEcCtD
Salicylate-sodium—Rash—Acamprosate—alcohol dependence	0.00183	0.00196	CcSEcCtD
Salicylate-sodium—Dermatitis—Acamprosate—alcohol dependence	0.00183	0.00195	CcSEcCtD
Salicylate-sodium—Headache—Acamprosate—alcohol dependence	0.00182	0.00194	CcSEcCtD
Salicylate-sodium—Dizziness—Naltrexone—alcohol dependence	0.00182	0.00194	CcSEcCtD
Salicylate-sodium—Chest pain—Citalopram—alcohol dependence	0.00182	0.00194	CcSEcCtD
Salicylate-sodium—Anxiety—Citalopram—alcohol dependence	0.00181	0.00193	CcSEcCtD
Salicylate-sodium—Confusional state—Citalopram—alcohol dependence	0.00176	0.00188	CcSEcCtD
Salicylate-sodium—Vomiting—Naltrexone—alcohol dependence	0.00175	0.00187	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Citalopram—alcohol dependence	0.00174	0.00186	CcSEcCtD
Salicylate-sodium—Oedema—Citalopram—alcohol dependence	0.00174	0.00186	CcSEcCtD
Salicylate-sodium—Rash—Naltrexone—alcohol dependence	0.00173	0.00185	CcSEcCtD
Salicylate-sodium—Dermatitis—Naltrexone—alcohol dependence	0.00173	0.00185	CcSEcCtD
Salicylate-sodium—Infection—Citalopram—alcohol dependence	0.00173	0.00185	CcSEcCtD
Salicylate-sodium—Nausea—Acamprosate—alcohol dependence	0.00173	0.00184	CcSEcCtD
Salicylate-sodium—Headache—Naltrexone—alcohol dependence	0.00172	0.00184	CcSEcCtD
Salicylate-sodium—Shock—Citalopram—alcohol dependence	0.00172	0.00183	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—ADH1A—alcohol dependence	0.0017	0.0272	CbGpPWpGaD
Salicylate-sodium—Tachycardia—Citalopram—alcohol dependence	0.0017	0.00182	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00169	0.0269	CbGpPWpGaD
Salicylate-sodium—Hyperhidrosis—Citalopram—alcohol dependence	0.00169	0.0018	CcSEcCtD
Salicylate-sodium—Anorexia—Citalopram—alcohol dependence	0.00166	0.00177	CcSEcCtD
Salicylate-sodium—Nausea—Naltrexone—alcohol dependence	0.00163	0.00174	CcSEcCtD
Salicylate-sodium—Hypotension—Citalopram—alcohol dependence	0.00163	0.00174	CcSEcCtD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—GGT2—alcohol dependence	0.0016	0.0256	CbGpPWpGaD
Salicylate-sodium—Paraesthesia—Citalopram—alcohol dependence	0.00157	0.00167	CcSEcCtD
Salicylate-sodium—Dyspnoea—Citalopram—alcohol dependence	0.00155	0.00166	CcSEcCtD
Salicylate-sodium—Somnolence—Citalopram—alcohol dependence	0.00155	0.00165	CcSEcCtD
Salicylate-sodium—Dyspepsia—Citalopram—alcohol dependence	0.00153	0.00164	CcSEcCtD
Salicylate-sodium—Decreased appetite—Citalopram—alcohol dependence	0.00152	0.00162	CcSEcCtD
Salicylate-sodium—Fatigue—Citalopram—alcohol dependence	0.0015	0.0016	CcSEcCtD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—GGT1—alcohol dependence	0.0015	0.0239	CbGpPWpGaD
Salicylate-sodium—Pain—Citalopram—alcohol dependence	0.00149	0.00159	CcSEcCtD
Salicylate-sodium—Constipation—Citalopram—alcohol dependence	0.00149	0.00159	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—ADH4—alcohol dependence	0.00145	0.0231	CbGpPWpGaD
Salicylate-sodium—Feeling abnormal—Citalopram—alcohol dependence	0.00144	0.00153	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00143	0.0229	CbGpPWpGaD
Salicylate-sodium—Gastrointestinal pain—Citalopram—alcohol dependence	0.00143	0.00152	CcSEcCtD
Salicylate-sodium—Urticaria—Citalopram—alcohol dependence	0.00139	0.00148	CcSEcCtD
Salicylate-sodium—Abdominal pain—Citalopram—alcohol dependence	0.00138	0.00147	CcSEcCtD
Salicylate-sodium—Body temperature increased—Citalopram—alcohol dependence	0.00138	0.00147	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Citalopram—alcohol dependence	0.00128	0.00137	CcSEcCtD
Salicylate-sodium—Asthenia—Citalopram—alcohol dependence	0.00125	0.00133	CcSEcCtD
Salicylate-sodium—Pruritus—Citalopram—alcohol dependence	0.00123	0.00132	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—ADH7—alcohol dependence	0.00123	0.0196	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Citalopram—alcohol dependence	0.00119	0.00127	CcSEcCtD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00119	0.019	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—GGT2—alcohol dependence	0.00118	0.0188	CbGpPWpGaD
Salicylate-sodium—Dizziness—Citalopram—alcohol dependence	0.00115	0.00123	CcSEcCtD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00115	0.0183	CbGpPWpGaD
Salicylate-sodium—Vomiting—Citalopram—alcohol dependence	0.00111	0.00118	CcSEcCtD
Salicylate-sodium—Rash—Citalopram—alcohol dependence	0.0011	0.00117	CcSEcCtD
Salicylate-sodium—Dermatitis—Citalopram—alcohol dependence	0.0011	0.00117	CcSEcCtD
Salicylate-sodium—Headache—Citalopram—alcohol dependence	0.00109	0.00117	CcSEcCtD
Salicylate-sodium—PTGS1—Biological oxidations—ADH1B—alcohol dependence	0.00108	0.0172	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—PDYN—alcohol dependence	0.00108	0.0172	CbGpPWpGaD
Salicylate-sodium—Nausea—Citalopram—alcohol dependence	0.00104	0.0011	CcSEcCtD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000955	0.0152	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000943	0.015	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—MAOB—alcohol dependence	0.000896	0.0143	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—ALDH2—alcohol dependence	0.000761	0.0121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000758	0.0121	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000614	0.00979	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP2E1—alcohol dependence	0.000609	0.0097	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—GGT1—alcohol dependence	0.000559	0.00891	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—MAOA—alcohol dependence	0.000501	0.00798	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000493	0.00786	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADH6—alcohol dependence	0.000352	0.00561	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—POMC—alcohol dependence	0.000326	0.0052	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—EP300—alcohol dependence	0.000305	0.00486	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADH1A—alcohol dependence	0.000292	0.00465	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADH6—alcohol dependence	0.000279	0.00445	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADH4—alcohol dependence	0.000248	0.00395	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADH1A—alcohol dependence	0.000231	0.00369	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000215	0.00342	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADH7—alcohol dependence	0.000211	0.00336	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GGT2—alcohol dependence	0.000202	0.00322	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADH4—alcohol dependence	0.000197	0.00314	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ADH1B—alcohol dependence	0.000185	0.00295	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.00017	0.00272	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADH7—alcohol dependence	0.000167	0.00267	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GGT2—alcohol dependence	0.00016	0.00256	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000158	0.00252	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MAOB—alcohol dependence	0.000153	0.00244	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ADH1B—alcohol dependence	0.000147	0.00234	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALDH2—alcohol dependence	0.00013	0.00208	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000125	0.002	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MAOB—alcohol dependence	0.000122	0.00194	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GOT2—alcohol dependence	0.000111	0.00177	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GOT2—alcohol dependence	0.000105	0.00167	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2E1—alcohol dependence	0.000104	0.00166	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALDH2—alcohol dependence	0.000103	0.00165	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	9.94e-05	0.00158	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GGT1—alcohol dependence	9.56e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GOT1—alcohol dependence	9.56e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GOT1—alcohol dependence	9.06e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GOT2—alcohol dependence	8.79e-05	0.0014	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MAOA—alcohol dependence	8.57e-05	0.00137	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	8.31e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2E1—alcohol dependence	8.26e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GGT1—alcohol dependence	7.59e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GOT1—alcohol dependence	7.59e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MAOA—alcohol dependence	6.8e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	6.59e-05	0.00105	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—POMC—alcohol dependence	5.58e-05	0.000889	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—POMC—alcohol dependence	4.43e-05	0.000706	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—EP300—alcohol dependence	3.7e-05	0.00059	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EP300—alcohol dependence	3.51e-05	0.000559	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—EP300—alcohol dependence	2.94e-05	0.000468	CbGpPWpGaD
